General - Press Releases

Date	Title	Company
01-Nov-2021	Laronde Expands Board of Directors with Leading Pharmaceutical Executives	Businesswire
01-Nov-2021	Imugene and Eureka Therapeutics Announce Strategic Collaboration to Accelerate Advancement of Oncolytic Virus and T-Cell Therapy in Solid Tumours	Businesswire
01-Nov-2021	Accenture Positioned as a Leader in IDC MarketScape: Worldwide Life Sciences Research & Development Vendor Assessment on IT Outsourcing for Fourth Consecutive Report	Businesswire
01-Nov-2021	TCT 2021 to Highlight Improved Patient Outcomes with Impella’s Small, Smart and Connected Technology	Businesswire
01-Nov-2021	2021 Report on the Keratoconjunctivitis Sicca Drugs In Development - ResearchAndMarkets.com	Businesswire
01-Nov-2021	$2.3 Billion Ion Exchange Resins Markets - Global Trajectory & Analytics, 2021-2026 - ResearchAndMarkets.com	Businesswire
01-Nov-2021	Nathan Jones, CEO of Xlear, Inc. Statement in Response to a Lawsuit Filed by the Department of Justice, on Behalf of the United States, Alleging That Certain Statements Made by Xlear Violated the FTC Act and the Consumer Protection Act	Businesswire
01-Nov-2021	Dr. Tal Zaks and Dr. Sheila Gujrathi Join OrbiMed	Businesswire
01-Nov-2021	A2 Bio to Highlight Program Updates in Two Presentations at SITC 2021	Businesswire
01-Nov-2021	McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS	Businesswire
01-Nov-2021	Gb Sciences Starts Preclinical Study for Plant-Based Formulas to Treat Depression and Anxiety	Newswire
01-Nov-2021	BELLUS Health Convenes Virtual Analyst Event to Discuss the Chronic Cough Landscape and its Selective P2X3 Antagonist BLU-5937	Businesswire
01-Nov-2021	KORU Medical Expands Senior Team to Accelerate Growth Strategy	Businesswire
01-Nov-2021	Moderna Announces Pledge to Achieve Net-Zero Carbon Emissions Globally by 2030	Businesswire
01-Nov-2021	Can-Fite’s Findings on Cannabis Compound’s Inhibition of Liver Cancer are Published in HEPATOLOGY and will be Presented at the AASLD’s The Liver Meeting® 2021 Conference	Businesswire
01-Nov-2021	ANI Pharmaceuticals Reports Third Quarter 2021 Results	Businesswire
01-Nov-2021	ANI Pharmaceuticals Announces FDA Approval of Purified Cortrophin™ Gel for Multiple Indications Including Multiple Sclerosis, Rheumatoid Arthritis and Nephrotic Syndrome	Businesswire
01-Nov-2021	Takeda Applied for Selection of “Prime Market”, Filed Corporate Governance Report With Tokyo Stock Exchange (TSE) in Line With Revised Corporate Governance Code and Published Corporate Governance Related Documents on its Website	Businesswire
01-Nov-2021	PureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage	Businesswire
01-Nov-2021	Nature’s Scientific Reports Features Gelesis’ Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage	Businesswire